Related Experiment Video
Updated: Jan 23, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Antiplatelet therapy for tibial balloon angioplasty: A clinical perspective
Costin N Ionescu1, Sophia E Altin1, Carlos Mena-Hurtado1
1Cardiovascular Disease Section, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Insights
Optimal antiplatelet therapy duration post tibial balloon angioplasty for critical limb ischaemia remains unclear. This review examines preclinical data to inform antiplatelet strategies in these high-risk patients.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Pharmacology
Background:
- Percutaneous transluminal tibial balloon angioplasty is crucial for critical limb ischaemia.
- No trials guide antiplatelet therapy post-intervention.
- Critical limb ischaemia patients have high comorbidity and bleeding risks.
Purpose of the Study:
- To examine the shortest duration of antiplatelet therapy post percutaneous transluminal tibial balloon angioplasty.
- To review preclinical data informing current angioplasty techniques.
Main Methods:
- Review of preclinical data.
- Analysis of existing angioplasty technique standards.
Main Results:
- Preclinical data review is ongoing.
- No specific results available from this review stage.
Conclusions:
- Further research is needed to establish evidence-based antiplatelet guidelines.
- Optimizing antiplatelet therapy is essential for critical limb ischaemia patients.
Abstract:
Percutaneous transluminal tibial balloon angioplasty has an important role in the therapeutic approach of critical limb ischaemia. Despite a growing number of patients with critical limb ischaemia, there are no trials to guide the pharmacologic approach post intervention. Guidelines pertaining to the antiplatelet therapy post percutaneous transluminal tibial balloon angioplasty have not been developed. In addition, critical limb ischaemia patients have multiple comorbidities and a higher risk of bleeding. To examine the shortest duration of antiplatelet therapy post percutaneous transluminal tibial balloon angioplasty, we reviewed the preclinical data used to develop the standards for the current angioplasty technique.
More Related Videos
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
The Behavioral Perspective on Personality
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
Social Cognitive Perspective on Personality
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

